EBV
Clinical trials for EBV explained in plain language.
Never miss a new study
Get alerted when new EBV trials appear
Sign up with your email to follow new studies for EBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial for new mono and Cancer-Linked virus vaccines
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study is testing the safety of two new experimental vaccines designed to prevent infection with Epstein-Barr virus (EBV), which causes mono and is linked to certain cancers and autoimmune diseases. The trial will enroll 750 healthy adults aged 18-29, including bo…
Matched conditions: EBV
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:30 UTC
-
New drug duo targets persistent 'Mono' virus in adults
Disease control Recruiting nowThis study is testing whether a combination of two drugs, golidocitinib and selinexor, can help control chronic active Epstein-Barr virus disease (CAEBVD) in adults. The goal is to reduce the amount of virus in the blood and improve disease symptoms. It is for adults aged 18-70 w…
Matched conditions: EBV
Phase: PHASE2, PHASE3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Scientists hunt for hidden immune flaws behind severe virus cases
Knowledge-focused Recruiting nowThis study aims to understand why some otherwise healthy people get extremely sick from common viruses like herpes, flu, or chickenpox. Researchers will examine 600 participants who have had severe, long-lasting, or hard-to-treat viral infections, along with some of their family …
Matched conditions: EBV
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC